ClinicalTrials.Veeva

Menu

Effect of Three Weeks Consumption of Rye Porridge Breakfast

S

Swedish University of Agricultural Sciences

Status

Unknown

Conditions

Obesity Prevention

Treatments

Other: dietary intervention (rye porridge or wheat bread)

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

Acute hunger-reducing effects (8h) has been documented for rye porridge breakfast compared with iso-caloric referenced refined wheat reference breakfast. The primary aim of the current study is to investigate whether this effects remains at regular consumption. A secondary aim is to compare the orocecal transit time (OCTT) between the two breakfasts.

Full description

The study is randomised and cross-over. During two 3-wk periods, separated by a 3-4-wks wash out, subjects will consume test breakfasts. During one of the periods test breakfast includes rye flake porridge and during the other period test breakfast include bread made from sifted wheat. The breakfast meals will be similar in calorie-, protein-, carbohydrate- and fat content. For all other days but 1, 8 and 22 of respective test period, the breakfast foods will be handed out to the participants along with instructions to exchange their ordinary breakfast with the test foods. During day 1, 8 and 22 the breakfasts will be served at the study centre.

Following measurements will be made:

  1. Subjective ratings of hunger, satiety and desire to eat during 24 h after breakfast on day 1, 8 and 22 during each 3-wk intervention period.
  2. on day 8 during each intervention period, orocecal transit time and breath hydrogen will be measured after intake of the breakfast.
  3. 3 day weighed food diaries will be taken at three occasions: at baseline and during the second week of each dietary intervention period.

Enrollment

26 estimated patients

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • man or woman aged between 20 and 60 years;
  • body mass index (BMI) 18-27 kg/m2;
  • habit of consuming breakfast, lunch and dinner every day;
  • and willingness to comply with the study procedures.

Exclusion criteria

  • intake of medicine likely to affect appetite or food intake;
  • any medical condition involving the gastrointestinal tract;
  • eating disorder;
  • smoking;
  • consumption of more than three cups of coffee per day;
  • change in body weight more than 10% during three months prior to screening;
  • consumption of any restricted diet such as vegan, gluten-free, slimming;
  • pregnancy, lactation or wish to become pregnant during the study period;
  • any known intolerance towards salazopyrin and similar substances

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

26 participants in 2 patient groups

Rye porrige breakfast
Experimental group
Treatment:
Other: dietary intervention (rye porridge or wheat bread)
Refined wheat reference bread breakfast
Active Comparator group
Treatment:
Other: dietary intervention (rye porridge or wheat bread)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems